Some studies have also investigated the prolactin-elevating properties of antipsychotics and its association with breast cancer development (Chou et al., 2017; Pottegård et al., 2018; Taipale et al., 2021; Rahman et al., 2022). Here, PRL is linked to breast carcinoma.